<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04699825</url>
  </required_header>
  <id_info>
    <org_study_id>cardiovascularpreeclampsia</org_study_id>
    <nct_id>NCT04699825</nct_id>
  </id_info>
  <brief_title>Cardiovascular Changes in Infants of Preeclampsia Mother</brief_title>
  <official_title>Cardiovascular Changes in the Infants of Mothers With Preeclampsia and Factors Associated With Neonatal Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preeclampsia (hypertension during pregnancy) is a common problem affecting 2-8% of&#xD;
      pregnancies worldwide and is typically diagnosed by increased blood pressure and proteinuria.&#xD;
      The rate of preeclampsia has increased since the 1980s with higher rates at extreme maternal&#xD;
      ages as well as during the first pregnancy. Pre-eclampsia is a serious hypertensive disorder&#xD;
      of pregnancy affecting outcomes for both mother and infants. These infants not only have&#xD;
      increased risk of neonatal complications including preterm birth, intrauterine growth&#xD;
      restriction, abnormal Doppler parameters, feed intolerance, intestinal problem, poor growth,&#xD;
      and long term lung condition but also have increased risk of cerebral palsy, abnormal&#xD;
      neurodevelopmental outcomes, cardiovascular disease, stroke, and mental disorders during&#xD;
      childhood and adulthood.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Preeclampsia is diagnosed according to the International Society for the Study of&#xD;
      Hypertension in Pregnancy (ISSHP) criteria: BP &gt; 140/90 on two occasions in previous&#xD;
      normotensive mother after 20 weeks of gestation and one of the following; proteinuria in&#xD;
      urine &gt; 0.3 gram/kg/day or acute kidney or liver dysfunction or signs of uterine dysfunction.&#xD;
      The onset of preeclampsia can be early before 34 weeks of pregnancy (Early-onset&#xD;
      preeclampsia) or late after 34 weeks of pregnancy (Late-onset preeclampsia). Early-onset&#xD;
      preeclampsia, especially between 28-32 weeks gestation, is characterized by a high prevalence&#xD;
      of microvascular changes in the placenta that makes mothers and their infants are more liable&#xD;
      to complication. The pathogenesis of preeclampsia is unclear.&#xD;
&#xD;
      Preeclampsia affects hematopoiesis and the fetal myeloid lineage leading to thrombocytopenia,&#xD;
      neutropenia, decrease phagocytic function, decrease T regulatory cells, and an increase in&#xD;
      cytotoxic natural killer cells in neonates. Innate and adaptive immunity are regulated by&#xD;
      myeloid cells and the immune changes in infants of preeclampsia mothers could lead to&#xD;
      increased incidence of neonatal sepsis and the development of chronic inflammatory&#xD;
      conditions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>enrollment of infants born from preeclampsia mother and control from infants born from normal pregnancies</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac changes</measure>
    <time_frame>within 72 hours after birth</time_frame>
    <description>cardiac output will be presented by ml/minute</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac function changes</measure>
    <time_frame>within 72 hours after birth</time_frame>
    <description>Fractional shortening and ejection fraction will be presented by percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vascular changes in superior mesenteric and anterior cerebral arteries</measure>
    <time_frame>72 hours after birth</time_frame>
    <description>Doppler parameters( peak-systolic velocity, end-diastolic velocity, and mean velocity.&#xD;
All will be measured in meter/second</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feeding problem</measure>
    <time_frame>3 months after birth</time_frame>
    <description>rate of necrotizing enterocolitis and feeding intolerance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oval all outcomes</measure>
    <time_frame>3 months</time_frame>
    <description>Rate of long term lung condition, sepsis, intraventricular hemorrhage and overall mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunological changes</measure>
    <time_frame>cord blood at birth</time_frame>
    <description>interleukins level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Pre-Eclampsia</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>new-born infants born from preeclampsia mother</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>new-born infants born from mothers with normal pregnancy matched with the same gestational age, sex and race</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiovascular and immunological changes</intervention_name>
    <description>performing cardiac ultrasound, vascular doppler, and immunological study on cord blood sample</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>study group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Infants born from Pregnant women with preeclampsia, their mother willing to give&#xD;
             consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1-Infant with a major heart problem.&#xD;
&#xD;
          -  Infants with major congenital and genetic anomalies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed S Ali</last_name>
    <phone>7309405405</phone>
    <email>ahmedsalehali@aun.edu.eg</email>
  </overall_contact>
  <reference>
    <citation>Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013 Nov 7;347:f6564. doi: 10.1136/bmj.f6564.</citation>
    <PMID>24201165</PMID>
  </reference>
  <reference>
    <citation>Hansen AR, Barn√©s CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr. 2010 Apr;156(4):532-6. doi: 10.1016/j.jpeds.2009.10.018. Epub 2009 Dec 14.</citation>
    <PMID>20004912</PMID>
  </reference>
  <reference>
    <citation>Marins LR, Anizelli LB, Romanowski MD, Sarquis AL. How does preeclampsia affect neonates? Highlights in the disease's immunity. J Matern Fetal Neonatal Med. 2019 Apr;32(7):1205-1212. doi: 10.1080/14767058.2017.1401996. Epub 2017 Nov 20. Review.</citation>
    <PMID>29113524</PMID>
  </reference>
  <reference>
    <citation>Bujold E, Chaiworapongsa T, Romero R, Gervasi MT, Espinoza J, Goncalves LF, Berman S, Yoon BH, Kim YM. Neonates born to pre-eclamptic mothers have a higher percentage of natural killer cells (CD3-/CD56+16+) in umbilical cord blood than those without pre-eclampsia. J Matern Fetal Neonatal Med. 2003 Nov;14(5):305-12.</citation>
    <PMID>14986803</PMID>
  </reference>
  <reference>
    <citation>Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006 Jul;195(1):40-9. Epub 2006 Apr 21. Review.</citation>
    <PMID>16813742</PMID>
  </reference>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2021</study_first_posted>
  <last_update_submitted>January 17, 2021</last_update_submitted>
  <last_update_submitted_qc>January 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>ASAli</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No, we will take consent from participant in this study only.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

